Intravenous and intranasal Muse cell administration delivers cognitive and histologic improvements in an Alzheimer’s disease model
Mari Dezawa(Tohoku University), Satoshi Kuroda(University of Toyama), Yo Oguma(Tohoku University), Dominik Duscher(Stanford University), Santosh Kesari(Cancer Institute (WIA)), Akio Yoneyama(SAGA Light Source), Shusuke Yamamoto(University of Toyama), Kohsuke Gonda(Tohoku University), Keitaro Shiraishi(University of Toyama), Yasumasa Kuroda(Mansoura University), Shohei Wakao(Tohoku University), Yoshihiro Kushida(Tohoku University), Kana Okawa-Abe(Tohoku University), Kentaro Fuji(National Institutes for Quantum Science and Technology)
Cited by 0
Related Papers
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation
|Journal of Clinical Investigation|2004|613
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540